最後更新 2024-05-14 07:27:32 (UTC+8)

基本分析

透過季節調整季營收,判斷美股整體趨勢,但注意股價有時候領先基本面的數據,應搭配其他領先指標判斷。

季營收趨勢 tooltip

季節調整季營收
季增率

5.2%


截至2024-03-31

基本資料

個股的基本資料,以及所屬的類股和產業。

公司介紹

業務介紹

Teleflex Incorporated設計、開發、製造和供應一次性醫療器械,用於全球關鍵護理和外科應用中的常見診斷和治療程序。它提供血管通路產品,包括Arrow品牌導管、導管導航和尖端定位系統,以及用於靜脈治療、血壓測量和通過單一穿刺點抽取血液樣本的骨內通路系統。該公司還提供介入產品,包括各種冠狀動脈導管、結構性心臟治療和周邊介入和心臟輔助產品,這些產品由介入心臟病學家、放射學家和血管外科醫生使用;以及Arrow品牌導管、Guideline和Trapliner導管、Manta血管封閉和Arrow Oncontrol設備。它還提供麻醉產品,如氣道和疼痛管理產品,以支持醫院、急診醫學和軍事渠道;以及外科產品,包括金屬和聚合物結扎夾和筋膜封閉外科系統,用於腹腔鏡手術、穿刺手術系統和其他外科器械。該公司還提供介入泌尿學產品,包括UroLift系統,一種用於治療良性前列腺增生引起的下尿路症狀的侵入性技術;以及呼吸產品,包括氧氣和氣霧治療、肺功能測試和通氣管理產品,用於各種護理環境中使用。它提供泌尿學產品,如導管、尿液收集器和導尿配件和產品,用於手術內泌尿學;以及膀胱管理服務。該公司為醫院和醫療服務提供者、醫療器械製造商和家庭護理市場提供服務。該公司成立於1943年,總部位於賓夕法尼亞州韋恩。

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

所屬產業

所屬類股
Healthcare
所屬產業
Medical - Instruments & Supplies

警語

1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。

2. 資料並不完整,需要完整資料請至相關網站索取。

3. 任何股市數據分析皆存在倖存者偏差。

warning